MHRA approves Covid-19 treatment for patients at-risk of severe disease

The UK’s medicines regulator has approved a Covid-19 treatment that has been found to cut the risk of hospitalisation and death by 79% in high-risk adults with the infection. Scientists have also said that preclinical data suggests it should work well against the latest variant…

The post MHRA approves Covid-19 treatment for patients at-risk of severe disease appeared first on Nursing Times.



0 comments:

Post a Comment